Intra-operative sonography: A valuable aid during breast-conserving surgery for occult breast cancer

Annals of Surgical Oncology

Volumn 14, Issue 11, 2007, Pages 3090-3101

  Haid, Anton ^a   Knauer, Michael ^a   Dunzinger, Stephanie ^a   Jasarevic, Zerina ^a   Köberle Wührer, Roswitha ^a   Schuster, Antonius ^a   Toeppker, Michael ^a   Haid, Bernhard ^a   Wenzl, Etienne ^a   Offner, Felix ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; OCCULT CANCER; PEROPERATIVE ECHOGRAPHY; SURGEON; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CELL DIFFERENTIATION; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MEDICAL RECORDS; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 35348838948     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9490-9     Document Type: Article

References (58)

1. Duffy SW, Tabar L, Vitak B, et al. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol 2003; 14(8):1196-8
2. Olsen AH, Njor SH, Vejborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330(7485):220
3. Nurko J, Edwards MJ. Image-guided breast surgery. Am J Surg 2005; 190(2):221-7
4. Gallagher WJ, Cardenosa G, Rubens JR, et al. Minimal-volume excision of nonpalpable breast lesions. AJR Am J Roentgenol 1989; 153(5):957-61
5. Buchberger W, Niehoff A, Obrist P, et al. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 2000; 21(4):325-36
6. Buman SJ, Clark DA. Breast intraoperative ultrasound: prospective study in 112 patients with impalpable lesions. ANZ J Surg 2005; 75(3):124-7
7. Schwartz GF, Goldberg BB, Rifkin MD, D'Orazio SE. Ultrasonography: an alternative to x-ray-guided needle localization of nonpalpable breast masses. Surgery 1988; 104(5):870-3
8. di Giorgio A, Arnone P, Canavese A. Ultrasound guided excisional biopsy of non-palpable breast lesions: technique and preliminary results. Eur J Surg 1998; 164(11):819-24
9. Rahusen FD, Taets van Amerongen AH, van Diest PJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins. J Surg Oncol 1999; 72(2):72-6
10. Henry-Tillman R, Johnson AT, Smith LF, Klimberg VS. Intraoperative ultrasound and other techniques to achieve negative margins. Semin Surg Oncol 2001; 20(3):206-13
11. Moore MM, Whitney LA, Cerilli L, et al. Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg 2001; 233(6):761-8
12. Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efficient according to results in 100 breast cancer patients. Am J Surg 2003; 186(4):378-82
13. Bennett IC, Greenslade J, Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg 2005; 29(3):369-74
14. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16(10):1569-83
15. Konstantiniuk P KE, Haid A, Bauer C, Steindorfer Peter. Das MCDBP (multi center database project). Acta Chir Austriaca 2001; 33:200-2001
16. Decker T, Ruhnke M, Schneider W. Standardized pathologic examination of breast excision specimen. Relevance within an interdisciplinary practice protocol for quality management of breast saving therapy. Pathologe 1997; 18(1):53-9
17. Obrist P, Brunhuber T, Ensinger C, et al. Pathological examination of breast biopsy specimens. Radiologe 2002; 42(1):1-5
18. Madjar H, Ohlinger R, Mundinger A, et al. BI-RADS-analogue DEGUM criteria for findings in breast ultrasound-consensus of the DEGUM Committee on Breast Ultrasound. Ultraschall Med 2006; 27(4):374-9
19. Madjar H, Mundinger A, Degenhardt F, et al. Quality control in breast sonography. Ultraschall Med 2003; 24(3):190-4
20. Buzdar AU, Ibrahim NK, Francis D, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005; 23(16):3676-85
21. Peintinger F, Symmans WF, Gonzalez-Angulo AM, et al. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 2006
22. Nurko J, Mancino AT, Whitacre E, Edwards MJ. Surgical benefits conveyed by biopsy site marking system using ultrasound localization. Am J Surg 2005; 190(4):618-22
23. Harlow SP, Krag DN, Ames SE, Weaver DL. Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma. J Am Coll Surg 1999; 189(3):241-6
24. Snider HC Jr., Morrison DG. Intraoperative ultrasound localization of nonpalpable breast lesions. Ann Surg Oncol 1999; 6(3):308-14
25. Smith LF, Rubio IT, Henry-Tillman R, et al. Intraoperative ultrasound-guided breast biopsy. Am J Surg 2000; 180(6):419-23
26. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14(5):1558-64
27. Blichert-Toft M RC, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992:19-25
28. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347(16):1233-41
29. van Dongen JA VA, Fentimen IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. Long-term results of a randomized trial comparing breast-conserving therapy with astectomy: European Organization for Research and treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000; 92:1143-50
30. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347(16):1227-32
31. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332(14):907-11
32. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995; 87(1):19-27
33. Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76(2):259-67
34. Klimberg VS, Harms S, Korourian S. Assessing margin status. Surg Oncol 1999; 8(2):77-84
35. Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003; 97(4):926-33
36. Taghian A, Mohiuddin M, Jagsi R, et al. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005; 241(4):629-39
37. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56(5):979-90
38. Dillon MF, Hill AD, Quinn CM, et al. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006; 13(3):333-9
39. Schwartz GF, Veronesi U, Clough KB, et al. Consensus conference on breast conservation, Milan, Italy, April 28-May 1, 2005. Breast J 2006; 12(4):398-407
40. Greene T, Tartter PI, Smith SR, Estabrook A. The significance of surgical margins for patients with atypical ductal hyperplasia. Am J Surg 2006; 192(4):499-501
41. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 1999; 85(3):616-28
42. Wong JS. Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ? Lancet Oncol 2006; 7(8):615-7
43. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184(5):383-93
44. Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004; 100(9):1823-32
45. Aziz D, Rawlinson E, Narod SA, et al. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer. Breast J 2006; 12(4):331-7
46. Swanson GP, Rynearson K, Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002; 25(5):438-41
47. Cellini C, Huston TL, Martins D, et al. Multiple re-excisions versus mastectomy in patients with persistent residual disease following breast conservation surgery. Am J Surg 2005; 189(6):662-6
48. Mendez JE, Lamorte WW, de Las Morenas A, et al. Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma. Am J Surg 2006; 192(4):538-40
49. Kaufman CS, Jacobson L, Bachman B, Kaufman L. Intraoperative ultrasound facilitates surgery for early breast cancer. Ann Surg Oncol 2002; 9(10):988-93
50. Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9(10):994-8
51. Gittleman MA. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg 2003; 186(4):386-90
52. Inoue T, Tamaki Y, Sato Y, et al. Three-dimensional ultrasound imaging of breast cancer by a real-time intraoperative navigation system. Breast Cancer 2005; 12(2):122-9
53. Rifkin MD, Schwartz GF, Pasto ME, et al. Ultrasound for guidance of breast mass removal. J Ultrasound Med 1988; 7(5):261-3
54. Paramo JC, Landeros M, McPhee MD, Mesko TW. Intraoperative Ultrasound-Guided Excision of Nonpalpable Breast Lesions. Breast J 1999; 5(6):389-94
55. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8(1):113-8
56. Huston TL, Pigalarga R, Osborne MP, Tousimis E. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 2006; 192(4):509-12
57. Van Goethem M, Tjalma W, Schelfout K, et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 2006; 32(9):901-10
58. Cassano E, Rizzo S, Bozzini A, et al. Contrast enhanced ultrasound of breast cancer. Cancer Imaging 2006; 6:4-6